Intra-Cellular Therapies, Inc. (ITCI) shares gained 7.31% today (2023-10-31). Is it the right time to buy?
What’s happening at Intra-Cellular Therapies, Inc. (NasdaqGS:ITCI)? What made the stock one of the top performing stock today? The company is indeed among the top gainers of the stock market, skyrocketing 7.31% (or 3.39 points) to $49.76 from its previous close of $46.37. So is it the right moment toRead More →